Title

Antithrombotic Therapy: Evaluation of the Safety of Performing Core Needle Biopsy of the Breast Without Suspending Medication
.

Authors

Patrice Cameron, Providence St. Vincent Medical Center
Jana Lesko, Providence St. Vincent Medical CenterFollow
Marla R London, Providence St. Vincent Medical CenterFollow

Document Type

Article

Publication Date

2-1-2018

Publication Title

Clinical journal of oncology nursing

Keywords

anticoagulants; antiplatelets; antithrombotic therapy; core needle breast biopsy

Abstract

BACKGROUND: Patients are increasingly presenting for outpatient breast biopsy while taking medically necessary antithrombotic therapy. Cessation of this medication prior to biopsy increases patients' risk of vascular complications. 
.

OBJECTIVES: This article evaluates the safety of performing core needle biopsies of the breast in patients without suspending prescription antithrombotic therapy. 
.

METHODS: In this retrospective chart review study, patients continued prescription antithrombotic therapy prior to and including the day of biopsy. Follow-up telephone assessment, relying on patient self-report, was completed on the same or next business day. The chart review included report of bleeding as a postprocedure complication.
.

FINDINGS: None of the 42 women who completed core needle biopsy of the breast while on antithrombotic therapy reported postdischarge bleeding, and 2 reported hematoma, supporting the safety of continuing antithrombotic therapy in patients who undergo core needle biopsy of the breast.

Clinical Institute

Cancer

Department

Oncology

Department

Nursing

Recommended Citation

Cameron, Patrice; Lesko, Jana; and London, Marla R, "Antithrombotic Therapy: Evaluation of the Safety of Performing Core Needle Biopsy of the Breast Without Suspending Medication
." (2018). Articles, Abstracts, and Reports. 52.
https://digitalcommons.providence.org/publications/52